Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
2022 AHA/ACC/HFSA Guideline for HF Management: Highlights & Implementation
Author(s): Michelle Kittleson Added: 2 years ago
In this video, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, Los Angeles, CA, US) provides her expert opinion on the 2022 ACC guidelines for the management of Heart Failure. Dr Kittleson outlines the applicability of these recommendations, as well as the barriers and opportunities. Recorded remotely from Beverley-Hills, 2022. Interviewer: Mirjam Boros View more

Heart Failure
2023 ACC/AHA/ACCP/HRS Guideline on AF Diagnosis & Management
Author(s): Jose A Joglar Added: 2 months ago
Dr Jose Joglar (UT Southwestern, US) joins us virtually to discuss the 2023 guidelines for atrial fibrillation (AF) diagnosis and management.These guidelines are an update to the 2014 document covering the full spectrum of managing patients with AF, from prevention to lifetime interventions, to rhythm and rate control, as well as special populations. A new classification of AF has been created,… View more

Standards & Guidelines

Electrophysiology & Arrhythmia
Optimizing GDMT for HFrEF During Hospitalization
Author(s): Neal M Dixit , Shivani Shah , Boback Ziaeian , et al Added: 2 years ago

Heart Failure
Implementing Heart Failure Guidelines with Collaborative Care
Start date: Aug 27, 2023 End date: Aug 27, 2023
Radcliffe Medical Education present a satellite symposium entitled ‘Implementing Heart Failure Guidelines with Collaborative Care’ at the ESC Congress 2023 in Amsterdam, NL. Join us in the Riga Lecture Room, or online, on Sunday 27 August 2023, from 12:45 to 13:45 CEST. This session, chaired by Prof Carolyn Lam (National Heart Centre Singapore, SG), provides an excellent opportunity for… View more

Heart Failure
George L Bakris
Research Area(s) / Expertise: Job title: President Elect
Dr George L. Bakris, MD, is a distinguished member of the National Kidney Foundation's Board of Directors. As the Professor of Medicine and Director of the Comprehensive Hypertension Center at the University of Chicago Medicine, he brings a wealth of expertise to the forefront of medical education.Previously serving as the Vice-Chairman of Preventive Medicine and Director of the Rush University… View more
Job title: Professor of vascular surgery and honorary consultant
Dr Alun Davies is a Professor of vascular surgery and honorary consultant at Imperial College London, UK. He has recently been appointed as the clinical director of Imperial College Private Healthcare. Prof Davies trained in Cambridge, Oxford, Plymouth, Boston (USA) and Bristol, prior to taking up a consultant appointment at Charing Cross Hospital in 1994. He is regarded as a world expert in the… View more
ESC 23: LODESTAR Trial
Author(s): Myeong-Ki Hong Added: 7 months ago
ESC 23 — Dr Myeong-Ki Hong (Yonsei University College of Medicine, KR) outlines the late-breaking results from the LODESTAR trial (NCT02579499). LODESTAR (Yonsei University) was a randomized, open-label multicenter trial that aimed to compare the clinical efficacy and safety of atorvastatin vs rosuvastatin for the secondary prevention of coronary artery disease. 4400 coronary artery disease… View more

Prevention & Chronic Conditions
ESC 23: New Guidelines For the Management of Acute Coronary Syndromes
Author(s): Robert A Byrne Added: 7 months ago
ESC 2023 — Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes. Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation… View more

Standards & Guidelines

MI/ACS
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR
Author(s): Duk-Woo Park Added: 2 years ago
In this short interview, Dr Duk-Woo Park (Asan Medical Center, KR) discusses the findings from the ADAPT-TAVR Randomized Clinical Trial (NCT03284827). The trial investigated Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR. Presented first at ACC.22, ADAPT-TAVR shows that the overall incidence of leaflet thrombosis on CT scans was less… View more

Anticoagulation
ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study
Author(s): Felix Mahfoud Added: 2 years ago
In this short late-breaking interview, Prof Felix Mahfoud (Saarland University Hospital, DE) discusses the 3-year efficacy outcomes of the SPYRAL HTN-ON MED Pilot Study (NCT02439775). The global clinical study, presented at ACC.22, tested the long-term effect of renal denervation (Symplicity Spyral™ multi-electrode renal denervation system, Medtronic Vascular) on blood pressure reduction in… View more

Prevention & Chronic Conditions

Intervention